Cargando…
Depletion of lncRNA MEG3 Ameliorates Imatinib-Induced Injury of Cardiomyocytes via Regulating miR-129-5p/HMGB1 Axis
Imatinib is a classical targeted drug to treat chronic myeloid leukemia (CML). However, it shows cardiotoxicity, which limits its clinical application. Long noncoding RNA (lncRNA) maternally expressed gene 3 (MEG3) shows proapoptotic properties in human cells. This study is performed to investigate...
Autores principales: | Tang, Peng, Zhou, Jinjian, Liu, Huagang, Mei, Shenglan, Wang, Kai, Ming, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673670/ https://www.ncbi.nlm.nih.gov/pubmed/38028435 http://dx.doi.org/10.1155/2023/1108280 |
Ejemplares similares
-
LncRNA MALAT1/miR‐129 axis promotes glioma tumorigenesis by targeting SOX2
por: Xiong, Zhiyong, et al.
Publicado: (2018) -
LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21
por: Zhou, Xiangyu, et al.
Publicado: (2017) -
The lncRNA MEG3 downregulation leads to osteoarthritis progression via miR-16/SMAD7 axis
por: Xu, Jin, et al.
Publicado: (2017) -
LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis
por: Liu, Dengtao, et al.
Publicado: (2020) -
Tumor-Suppressive Function of lncRNA-MEG3 in Glioma Cells by Regulating miR-6088/SMARCB1 Axis
por: Gong, Xin, et al.
Publicado: (2020)